Vaping More Effective Than Nicotine Replacement Therapies for Quitting Smoking

A recent study conducted in Australia has revealed that vaping may be significantly more effective than traditional nicotine replacement therapies (NRTs), such as nicotine gum and lozenges, in aiding smokers to quit. The research, published in the *Annals of Internal Medicine* on July 14, 2025, indicates that six-month smoking abstinence rates among participants using flavored nicotine-laced vape devices were three times higher than those using NRTs.

The study, led by Ryan Courtney, Associate Professor at the National Drug and Alcohol Research Center at the University of New South Wales, involved over 1,000 Australians who were receiving government assistance and expressed interest in quitting smoking. Participants were randomly assigned to either the vaping group, which received an eight-week supply of flavored vape juice, or the NRT group, which was provided with nicotine gum or lozenges. Both groups received automated text messages offering behavioral support for five weeks.

Results showed that 28% of the vape group remained smoke-free after six months, compared to just under 10% in the NRT group. This finding suggests that flavored vapes might enhance the quitting process, particularly for individuals experiencing social disadvantages. "Vaporized nicotine products were more effective than nicotine replacement therapy for smoking cessation," the research team concluded.

However, the study also raised concerns regarding the long-term health implications of vaping. While switching from traditional cigarette smoking to vaping is believed to reduce health risks, the long-term effects of vaping remain largely unknown. Researchers noted that emerging data indicate potential impacts on cardiovascular health, prompting calls for further investigation into the health effects of long-term vaping.

The U.S. has imposed restrictions on flavored tobacco products, which has led to a rise in the illegal market for kid-friendly flavors such as fruit and menthol. According to the U.S. Food and Drug Administration, these restrictions are part of a broader effort to curb youth access to nicotine products, yet illegal sales persist.

Prominent health experts emphasize the need for cautious interpretation of these findings. Dr. Sarah Johnson, Professor of Public Health at Johns Hopkins University, stated, "While vaping may offer a pathway for some smokers to quit, the health consequences of long-term use need thorough evaluation." Additionally, Dr. Mark Thompson, Director of the Tobacco Control Research Program at the World Health Organization, highlighted the importance of comprehensive smoking cessation strategies that consider both the benefits and risks associated with vaping.

As public health officials contemplate the implications of these findings, it remains crucial to balance the potential benefits of vaping as a cessation tool with the uncertainties surrounding its long-term health effects. Policymakers are urged to consider evidence-based approaches to smoking cessation that prioritize overall public health outcomes and the well-being of future generations.